Αρχική World News News digest – Genetic links to male breast cancer, bowel cancer checks...

News digest – Genetic links to male breast cancer, bowel cancer checks and shorter radiotherapy is effective

Breast cancer cell image (credit: LRI EM department)

Study claims young people up to seven times more likely to contract coronavirus

Teens and young adults who use e-cigarettes could be five to seven times more likely than non-smokers to catch coronavirus, new research suggests. The study linked vaping to an increased risk in young people developing symptoms such as coughing, fever, tiredness and difficulty breathing. Findings come after researchers at the University of Tasmania analysed survey responses from over 4,351 people aged between 13 and 24, who smoked both tobacco and e-cigarettes.

Despite the headlines, this “7 times more likely” figure includes people who’ve used tobacco and e-cigarettes “ever” alongside with those who’ve just used both in the last 30 days. When looking at the individuals who only used e-cigarettes in the last 30 days, there was no significant increase in COVID-19 diagnosis. Find out more at The Independent.

Three new genetic variants linked to male breast cancer

Research funded by Breast Cancer Now has discovered three new genetic changes that increase the risk of breast cancer in men. New findings bring the total number of known common genetic changes linked to male breast cancer to five. Around 370 men are diagnosed with breast cancer every year in the UK, with 80 dying of the disease. Scientists say the findings could lead to better risk testing for male breast cancer, as well as development of new preventative drugs. Full story at The Institute of Cancer Research.

Half of under-50s delay bowel cancer checks

iNews has reported the findings from Bowel Cancer UK showing that half of under-50s in Britain are unaware they could develop bowel cancer, despite displaying “red flag” symptoms. According to figures, a third of people in this age category delay seeing their GP for three months, with 40% visiting their doctor at least three times before being referred for further tests. The charity warns that delays in seeking medical advice is leading to younger people being diagnosed with the disease at an advanced stage. You can find out how to safely access your GP services on the NHS website.

Shorter radiotherapy just as effective for fighting cancer

The Times reports that early-stage cancer patients are benefiting from modified radiotherapy treatment across the NHS in response to the pandemic. Researchers have shown that a smaller number of larger radiotherapy doses can cut radiotherapy treatment from four weeks to five days, meaning patients need fewer hospital visits. The decision has been backed up in a pioneering study by the Institute of Cancer Research, which found women with early-stage breast cancer can be successfully treated in this way.

And finally…

A “game-changing” scan that creates a GPS-style map of patients’ lungs is being used to detect early signs of cancer. The electromagnetic navigation bronchoscopy (ENB) uses GPS-like technology to build a 3D image of the lungs, highlighting tumours that are too small or awkwardly placed to be spotted by routine scans. Glan Clwyd Hospital in Denbighshire has become the second hospital in the UK to use the technology, after St Bartholomew’s Hospital in London. Full story at BBC.

Scarlett Sangster is a writer for PA Media Group

More on this topic



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Avapritinib Not Superior to Regorafenib in Terms of Median PFS in Third-Line or Later Treatment of Patients with Unresectable or Metastatic GIST

Findings from an open-label, randomised, multicentre phase III VOYAGER study indicate that avapritinib is not superior to regorafenib in terms of median progression-free survival...

Patients less likely to rate cancer care as ‘very good’ during pandemic

Almost a third of cancer patients have reported receiving worse care since COVID-19 began, according to a new survey commissioned by Cancer Research UK. Whilst...

How to Avoid Spreading Harmful Chemo Chemicals to Members of Your Household

Cancer is not contagious, and neither is chemotherapy. However, harmful chemotherapy drugs can sometimes still be present in the bodily fluids of a person...

Can’t Sleep? Tips for Coping with Insomnia

Insomnia* is common for cancer patients**, as well as for the general population. We frequently hear from our patients and their caregivers that sleeping through the night...

New Task Force Focuses on Quality of Life for AYAs with Cancer

August 4, 2021, by NCI Staff Adolescents and young adults are using mobile devices to document the impact of cancer and its treatment on their...

Amivantamab Demonstrates Robust Efficacy in Patients with EGFR Exon 20 Insertion-Mutated NSCLC

Amivantamab demonstrated robust and durable responses in patients with epidermal growth factor receptor Exon 20 insertion (EGFR Exon20ins)-mutated non-small cell lung cancer (NSCLC) after progression on...